Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ophthotech
Biotech
Iveric latest to be hit by COVID-19 as it delays a key trial
Iveric Bio has been forced to hit the pause button for a pivotal test on its leading drug Zimura as COVID-19 continues to back up clinical trials.
Ben Adams
Mar 18, 2020 9:15am
Ophthotech (now Iveric) hits eye drug goals as shares jump
Oct 28, 2019 8:03am
Ophthotech becomes Iveric in pivot to gene therapies
Apr 16, 2019 9:55am
Apellis says timeline still on track for stalled eye drug
Dec 20, 2018 10:39am
Ophthotech adds to pipeline again as climb back continues
Oct 31, 2018 12:02pm
Ophthotech completes clean sweep of phase 3 trial flops
Aug 14, 2017 9:00am
